Table 3.

Hazard Ratios for 6‐Month Clinical Outcomes in the Matched Cohort for Each LDL‐C Cholesterol Decile

	Statins		Statins vs No Statins
Endpoint	Yes	No	Hazard Ratio (95% CI)	P Value
LDL‐C ≤ 113 mg/dL, n = 1031
Death, recurrent MI, or revascularization	97 (9.4)	113 (11.0)	0.847 (0.646–1.111)	0.230
Death or recurrent MI	85 (8.2)	103 (10.0)	0.814 (0.611–1.085)	0.160
Death from any cause	74 (7.2)	100 (9.7)	0.728 (0.539–0.984)	0.039
Death from cardiac cause	54 (5.2)	74 (7.2)	0.719 (0.506–1.021)	0.066
Death from noncardiac cause	20 (1.9)	26 (2.5)	0.754 (0.421–1.351)	0.343
LDL‐C ≤ 105 mg/dL, n = 876
Death, recurrent MI, or revascularization	83 (9.5)	87 (9.9)	0.945 (0.700–1.277)	0.713
Death or recurrent MI	71 (8.1)	79 (9.0)	0.890 (0.646–1.226)	0.476
Death from any cause	61 (7.0)	76 (8.7)	0.793 (0.566–1.111)	0.177
Death from cardiac cause	44 (5.0)	56 (6.4)	0.777 (0.523–1.153)	0.210
Death from noncardiac cause	17 (1.9)	20 (2.3)	0.838 (0.439–1.600)	0.593

Abbreviations: CI, confidence interval; LCL‐C, low‐density lipoprotein cholesterol; MI, myocardial infarction.

Data are expressed as n (%).